Effect of Nano-structured Alumina Coating on the Bond Strength of Zirconia Resin-bonded Fixed Dental Prostheses
NCT ID: NCT04693949
Last Updated: 2023-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2018-01-03
2024-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study adopts a prospective, randomized, controlled, double-blind design contrasting the use of NAC to air-borne particle abrasion (APA) (control) as a surface pretreatment method of zirconia RBFDPs used for replacing missing central or lateral incisors. The primary outcome evaluated is the retention/survival of the zirconia RBFDPs pretreated with APA and NAC.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Single Retainer All-Ceramic Resin-bonded Fixed Dental Protheses
NCT01411592
Two-piece Zirconia Implants With Two Various Platforms
NCT06012071
Natural Dentition, Prosthesis and Antagonist Wear 3D Analysis
NCT05637619
Aesthetic Outcomes of Single Tooth Implant Using Metal Ceramic Restorations With Either Zirconia or Titanium Abutments
NCT02315794
Properties and Clinical Performance of Zirconia-based Dental Ceramics
NCT00737308
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study adopts a prospective, randomized, controlled, double-blind design contrasting the use of NAC to air-borne particle abrasion (APA) as a surface pretreatment method of zirconia RBFDPs. Healthy patients in need of a missing central or lateral incisor replacement are screened and rated to be eligible by two calibrated dentists. RBFDPs are randomly allocated into two groups and inserted by the same operator. The first group, where the bonding surface is pretreated with APA serves a control group. In the second group the restorations are pretreated with NAC. The participants and the operator are blinded to the group assignment in a double-blinded trial design. The primary outcome evaluated is the retention/survival of the RBFDP. Non-parametric tests and Kaplan-Meyer analysis will be used to determine differences between both study groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
APA
Air-borne particle abrasion of zirconia RBFDPs prior to bonding
APA
Air-borne particle abrasion of zirconia RBFDPs prior to bonding
NAC
Pretreatment of zirconia RBFDP with nanostructured alumina coating after milling of RBFDP's framework
NAC
Pretreatment of zirconia RBFDP with nanostructured alumina coating after milling of RBFDP's framework
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NAC
Pretreatment of zirconia RBFDP with nanostructured alumina coating after milling of RBFDP's framework
APA
Air-borne particle abrasion of zirconia RBFDPs prior to bonding
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. signs of bruxism
3. abutment tooth with active periodontal or periapical disease
4. inadequate enamel bonding surface of the abutment tooth
5. inadequate interocclusal space for a retainer wing and a proximal connector
6. pontic guidance
7. physical or psychological disease likely to interfere with normal conduct of the study
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Ljubljana, Faculty of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical Faculty - University of Ljubljana Ljubljana
Ljubljana, , Slovenia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Adhesion of RBFDPs
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.